Seizure Prediction Shows Promise But Is Not Ready Yet

What was studied

This paper is a review, not a new experiment. It examined the field of seizure forecasting research and discussed its progress toward clinical use in epilepsy care. The authors incorporated perspectives presented at a 2025 epilepsy digital health meeting.

The review covers forecasting methods that use several kinds of data, including chronic EEG recordings, wearable physiological signals, and self-reported seizure diaries. It focuses on barriers to turning promising research tools into systems that are useful, safe, and approved for real-world clinical use.

What they found

The review says seizure forecasting has progressed as a research field. Research suggests seizure risk is often not completely random and may fluctuate with identifiable biological rhythms and patient-specific patterns. Forecasting tools have shown promising performance in retrospective datasets using intracranial EEG, subscalp recordings, wearable signals, and diaries.

At the same time, the authors say clinical translation remains limited. Prospective real-world validation and regulatory approval of patient-facing systems remain rare. The review argues that forecasting performance cannot be judged in isolation from how the forecast will be used. Lower-risk uses, such as scheduling diagnostic monitoring or visualizing historical trends, may require different performance thresholds than higher-risk uses, such as medication titration or adaptive neuromodulation.

The paper also highlights major barriers: reliable seizure annotation, changes over time in biological cycles, practical constraints for real-time deployment, and ethical concerns related to reliance on low-risk states, anxiety from high-risk advisories, and differences in patient preferences and risk tolerance.

Limits of the evidence

Because this is a review, it does not provide one new prospective test of a forecasting device in patients. It summarizes the field and the authors' interpretation of the evidence. The abstract does not give detailed numbers on performance, how many studies were included, or how strong the evidence was for each type of approach.

The paper cannot show from the abstract alone that seizure forecasting improves health, safety, or quality of life in routine care. It also cannot determine which forecasting method is best for different age groups or epilepsy types based on the abstract alone.

For families and caregivers

For families, this review suggests that seizure forecasting is a promising area, but it is not yet a standard tool for most people with epilepsy. In the future, forecasts might help with planning, arranging monitoring, or understanding patterns over time.

The review also gives an important caution: a forecast is not the same as certainty. Families may want tools that are accurate, easy to understand, and tested in real life before relying on them for important decisions. The paper supports careful implementation and rigorous evaluation rather than quick adoption.

What to watch next

Stronger evidence would come from rigorous prospective real-world studies using transparent benchmarks and clearly defined use cases, and from studies showing whether forecasting tools improve clinically meaningful outcomes such as quality of life, anxiety, locus of control, or other patient-reported outcomes.

Terms in this summary

seizure forecasting

Using patterns in data to estimate when seizure risk may be higher or lower.

EEG

A test that records the brain's electrical activity.

intracranial EEG

EEG recorded from electrodes placed inside the skull or on the brain.

prospective validation

Testing a tool forward in time in real-world use, rather than only on past data.

regulatory approval

Official review by health authorities to decide whether a medical product can be marketed for a specific use.

nonstationarity

The idea that biological or seizure-related patterns can change over time, making forecasting harder.

neuromodulation

Treatment that changes nerve or brain activity, often using electrical stimulation.

patient-reported outcomes

Measures reported by patients, such as quality of life, anxiety, or feeling in control.